Singapore launches its first national Embodied AI Challenge for Manufacturing, bringing together global teams to develop and ...
A*STAR and VDL ETG join forces to accelerate technology and manufacturing development for fusion and extreme-environment ...
Enabling aspiring researchers to pursue PhD studies in biomedical sciences, chemistry, physics, engineering, and related fields. Scholars gain research experience at A*STAR and contribute to impactful ...
MTC MISSION funds sector-aligned, mission-driven R&D with clear pathways to industry deployment and outsized commercial impact within 10 years. Programmes are capped at 5 years; successful ones may ...
In an era where Artificial Intelligence (AI) and digital technologies are revolutionizing industries, leaders must evolve to navigate the complexities of this digital landscape. The transformation ...
A full-spike SARS-CoV-2 serology platform designed to improve the detection and characterization of COVID-19 antibodies. The most widely deployed commercial assays to detect COVID-19 antibodies share ...
Skin Disease affects nearly a quarter of the World’s population and ranks among the leading causes of disability, profoundly affecting quality of life. The Skin Disease Theme envisions transforming ...
Genetic cardiomyopathies are life-limiting heart conditions with no approved treatments to slow progression. Affecting adults in their prime, they often lead to heart failure and, ultimately, ...
Dr Florian Winau is an immunologist whose research focuses on lymphocyte biology, antigen presentation and the role of lipids in immune responses. He studied medicine in Berlin, Paris and London, and ...
Source: The Business Times © SPH Media Limited. Permission required for production. The innovation gap refers to the distance between a strong scientific result and ...
A*StartCentral marks its 10th anniversary with doubled footprint and sector-specific pathways to strengthen Singapore's pipeline of globally competitive deep tech companies (Left to right) Ms Irene ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results